Last checked at 10 Jan 2022 15:30
10 January 2022
Reach
Microsaic Systems plc
("Microsaic" or "Company")
Investor Presentation
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces that on 12 January 2022, the Company's CEO, Glenn Tracey, will provide a live presentation at 10:00 am GMT via the Investor Meet Company platform, relating to the Pre-Close Trading Update issued on 10 January 2022.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00 am GMT the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Microsaic Systems plc via:
https://www.investormeetcompany.com/microsaic-systems-plc/register-investor
Investors who already follow Microsaic Systems plc on the Investor Meet Company platform will automatically be invited.
Enquiries: |
| |
Microsaic Systems plc Glenn Tracey, CEO
| +44 (0)1483 751 577 | |
Singer Capital Markets(Nominated Adviser & Joint Broker) | +44 (0)20 7496 3000 | |
Aubrey Powell / George Tzimas / Tom Salvesen
|
| |
|
| |
|
| |
Turner Pope Investments (TPI) Limited(Joint Broker) Andy Thacker / James Pope | +44 (0) 20 3657 0050 | |
|
|
|
|
|
|
About Microsaic
Microsaic develops and commercialises globally micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need: whether within a human health environment; conventional laboratory setting; within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow; or in front-line environmental monitoring.